Overview
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 13
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 9, 2026 | Phase 2 Study Evaluates Investigational Biologic Derived From Human Birth Tissue for Dry Eye Disease | Investigational therapy shows favorable safety profile; highest dose associated with greatest improvements in dry eye symptoms and corneal staining MIAMI, FL, UNITED STATES, October 9, 2026 /EINPresswire.com/ -- BioTissue will present resul... |
| Oct 5, 2026 | BioTissue Appoints Rocco Venezia, CPA, as Chief Financial Officer | MIAMI, NY, UNITED STATES, October 5, 2026 /EINPresswire.com/ -- BioTissue, a leader in regenerative healing across the ocular surface disease continuum, today announced the appointment of Rocco Venezia, CPA, as Chief Financial Officer. Vene... |
| Sep 30, 2026 | Scientific Posters Explore Cryopreserved Amniotic Membrane (CAM) in Complex Ocular Surface Conditions | Case Reports Describe Clinical Outcomes in Neurotrophic and Herpetic Keratitis MIAMI, FL, UNITED STATES, September 30, 2026 /EINPresswire.com/ -- Two scientific posters being presented at the American Academy of Optometry’s annual meeting, ... |
| Aug 24, 2026 | BioTissue Appoints Ophthalmic Industry Leader Chris Calcaterra to Board of Directors | Chris Calcaterra, Board of Directors, BioTissue Addition Brings Proven Commercial Expertise as BioTissue Advances Its Ocular Health Strategy MIAMI, FL, UNITED STATES, August 24, 2026 /EINPresswire.com/ -- BioTissue, a leader in regenerative... |
| Mar 19, 2026 | BioTissue Named to Great Place to Work® for Third Consecutive Year | BioTissue Named to Great Place to Work® for Third Consecutive Year BioTissue, the pioneer of cryopreserved human birth tissue products, has been certified as a Great Place to Work® for the third consecutive year. MIAMI, FL, UNITED STATES, M... |
| Aug 1, 2025 | BioTissue Receives Contract from Vizient for Regenerative Biologics | Vizient Hospital Clients Now Have Enhanced Access to Full BioTissue Regenerative Healing Product Portfolio MIAMI, FL, UNITED STATES, August 1, 2025 /EINPresswire.com/ -- BioTissue Surgical Inc., a pioneer in the clinical application of huma... |
| Mar 1, 2021 | TissueTech Receives U.S. Food and Drug Administration Clearance to Proceed with Clinical Study using Investigational New Drug TTBT01 | |
| Jun 23, 2015 | TissueTech Completes $15M Series B Financing | TissueTech, Inc., a Miami, FL-based regenerative tissue engineering company, completed a $15m Series B financing. Backers included River Cities Capital Funds and Ballast Point Ventures. Led by Amy Tseng, CEO., and Dr. Scheffer Tseng, MD, Ph... |
| May 13, 2015 | TissueTech Receives $10M Credit Facility | TissueTech, Inc., a regenerative tissue-engineering company, received a $10m credit facility. Square 1 Bank, the banking partner to entrepreneurs and the venture capital community, provided the financing. The company intends to use the proc... |
Reviews 0
FAQ about BioTissue
When was BioTissue founded?
BioTissue was founded in 1997.
What has the press written about BioTissue?
Parsers VC has collected 13 articles mentioning BioTissue, among them “Phase 2 Study Evaluates Investigational Biologic Derived From Human Birth Tissue for Dry Eye Disease” (Oct 9, 2026) and “BioTissue Appoints Rocco Venezia, CPA, as Chief Financial Officer” (Oct 5, 2026).
Is BioTissue still active?
Yes, BioTissue is active; its latest activity on Parsers VC dates from Oct 16, 2026.